The creator of CRISPR babies is flirting again with infamy, this time through a mysterious alliance with an Internet-savvy ...

The Therapeutic BCG Vaccine Market offers growth opportunities through expanding applications beyond TB prevention, including bladder cancer and autoimmune diseases. Advances in biotechnology, ...

Investors interested in the Genomics and Synthetic Biology theme may consider adding these three stocks to their portfolio - Intellia Therapeutics (NTLA), uniQure (QURE) and Verve Therapeutics (VERV).

For centuries, yeast has been an essential ingredient in the production of wine and bread. Scientists are able to adjust ...

Synthetic biology has grown exponentially in less than a decade, with CRISPR gene-editing as the ... living through the early stages of the ‘biotech century’, as economic and social theorist ...

U.S. technology is set to “do very well” under the administration of President Trump, and one sector in particular, said Ark ...

BURLINGAME, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Biotechnology Market is estimated to be valued at USD 1,034.63 Bn in 2025 and is expected to reach USD 2,330.47 Bn in 2032, exhibiting ...

To remain relevant in an interconnected ecosystem, biopharma must go beyond optimising yesterday’s markets and begin ...

STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.

This study set out to answer that question using cutting-edge biotechnology. The team used CRISPR-Cas9 to engineer several ALS-causing mutations—including FUS P525L, FUS R495X, and TARDBP M337V ...

This is the first gene editor to use a CRISPR-associated transposase to make targeted edits at therapeutically useful levels ...